Stocks News

LAST PRICE
97.6200
TODAY'S CHANGE (%)
Trending Up1.2400 (1.2866%)

Bid / Lots
---/ ---
Ask / Lots
---/ ---
Open / Previous Close
96.6100 / 96.3800
Day Range
Low 95.7500
High 98.0000
52 Week Range
Low 70.3900
High 121.9000
Volume
542,252
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 22, 2024
- Blueprint Medicines Insider Sold Shares Worth $1,869,658, According to a Recent SEC Filing, from 4:53PM ET on Friday Nov 22, 2024 by MT Newswires
  4:53PM ET on Friday Nov 22, 2024 by MT Newswires
  Companies Mentioned: BPMC
  04:53 PM EST, 11/22/2024 (MT Newswires) -- Lonnel Coats, Director, on November 20, 2024, sold 19,824 shares in Blueprint Medicines (BPMC) for $1,869,658. Following the Form 4 filing with the SEC, Coats has control over a total of 2,242 shares of the...
Nov 18, 2024
- DJ Blueprint Medicines Price Target Maintained With a $125.00/Share by JMP Securities, from 1:03PM ET on Monday Nov 18, 2024 by Dow Jones
  1:03PM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: BPMC
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BPMC/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 18, 2024 13:03 ET (18:03 GMT)
Nov 15, 2024
- DJ Blueprint Medicines Price Target Maintained With a $135.00/Share by HC Wainwright & Co., from 6:42AM ET on Friday Nov 15, 2024 by Dow Jones
  6:42AM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: BPMC
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BPMC/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 15, 2024 06:42 ET (11:42 GMT)
- DJ Blueprint Medicines Price Target Maintained With a $135.00/Share by Needham, from 5:17AM ET on Friday Nov 15, 2024 by Dow Jones
  5:17AM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: BPMC
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BPMC/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 15, 2024 05:17 ET (10:17 GMT)
Nov 14, 2024
- DJ Blueprint Medicines Initiated at Overweight by JP Morgan, from 7:48AM ET on Thursday Nov 14, 2024 by Dow Jones
  7:48AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: BPMC
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BPMC/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 14, 2024 07:48 ET (12:48 GMT)

Yesterday
- The Schall Law Firm Encourages Stockholder Contributions To An Inquiry Into ADMA Biologics Inc's Possible Securities Law Violations, from 13 hours ago by Accesswire
  13 hours ago by Accesswire
  Companies Mentioned: ADMA
- The Schall Law Firm Encourages Stockholder Contributions To An Inquiry Into ADMA Biologics Inc's Possible Securities Law Violations, from 13 hours ago by Dow Jones
  13 hours ago by Dow Jones
  Companies Mentioned: ADMA
Dec 1, 2024
- ADMA Biologics, Inc. Is Being Investigated For Fraud And Impacted Investors Are Invited To Contact The Schall Law Firm, from 3:16PM ET on Sunday Dec 01, 2024 by Accesswire
  3:16PM ET on Sunday Dec 01, 2024 by Accesswire
  Companies Mentioned: ADMA
- ADMA Biologics, Inc. Is Being Investigated For Fraud And Impacted Investors Are Invited To Contact The Schall Law Firm, from 3:16PM ET on Sunday Dec 01, 2024 by Dow Jones
  3:16PM ET on Sunday Dec 01, 2024 by Dow Jones
  Companies Mentioned: ADMA
Nov 30, 2024
- The Schall Law Firm Encourages Shareholders With Losses To Join An Inquiry Into ADMA Biologics Inc For Securities Law Violations, from 11:01AM ET on Saturday Nov 30, 2024 by Accesswire
  11:01AM ET on Saturday Nov 30, 2024 by Accesswire
  Companies Mentioned: ADMA
- The Schall Law Firm Encourages Shareholders With Losses To Join An Inquiry Into ADMA Biologics Inc For Securities Law Violations, from 11:01AM ET on Saturday Nov 30, 2024 by Dow Jones
  11:01AM ET on Saturday Nov 30, 2024 by Dow Jones
  Companies Mentioned: ADMA
Nov 29, 2024
- ADMA Biologics, Inc. Is Being Investigated For Committing Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm, from 12:31PM ET on Friday Nov 29, 2024 by Accesswire
  12:31PM ET on Friday Nov 29, 2024 by Accesswire
  Companies Mentioned: ADMA
- ADMA Biologics, Inc. Is Being Investigated For Committing Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm, from 12:30PM ET on Friday Nov 29, 2024 by Dow Jones
  12:30PM ET on Friday Nov 29, 2024 by Dow Jones
  Companies Mentioned: ADMA
- TG Therapeutics to Participate in the Evercore HealthCONx Conference, from 8:00AM ET on Friday Nov 29, 2024 by Dow Jones
  8:00AM ET on Friday Nov 29, 2024 by Dow Jones
  Companies Mentioned: TGTX
Nov 27, 2024
- The Schall Law Firm Invites Stockholder Contributions To An Inquiry Into ADMA Biologics Inc's Securities Law Violations, from 12:45PM ET on Wednesday Nov 27, 2024 by Accesswire
  12:45PM ET on Wednesday Nov 27, 2024 by Accesswire
  Companies Mentioned: ADMA

Blueprint Medicines Corp
NASDAQ:BPMCUnited States

Search Criteria

Nov 22, 2024

Blueprint Medicines Insider Sold Shares Worth $1,869,658, According to a Recent SEC Filing, from 4:53PM ET on Friday Nov 22, 2024 by MT Newswires

Nov 18, 2024

DJ Blueprint Medicines Price Target Maintained With a $125.00/Share by JMP Securities, from 1:03PM ET on Monday Nov 18, 2024 by Dow Jones

Nov 15, 2024

DJ Blueprint Medicines Price Target Maintained With a $135.00/Share by HC Wainwright & Co., from 6:42AM ET on Friday Nov 15, 2024 by Dow Jones

DJ Blueprint Medicines Price Target Maintained With a $135.00/Share by Needham, from 5:17AM ET on Friday Nov 15, 2024 by Dow Jones

Nov 14, 2024

DJ Blueprint Medicines Initiated at Overweight by JP Morgan, from 7:48AM ET on Thursday Nov 14, 2024 by Dow Jones

Peers Headlines

Yesterday

The Schall Law Firm Encourages Stockholder Contributions To An Inquiry Into ADMA Biologics Inc's Possible Securities Law Violations, from 13 hours ago by Accesswire

The Schall Law Firm Encourages Stockholder Contributions To An Inquiry Into ADMA Biologics Inc's Possible Securities Law Violations, from 13 hours ago by Dow Jones

Dec 1, 2024

ADMA Biologics, Inc. Is Being Investigated For Fraud And Impacted Investors Are Invited To Contact The Schall Law Firm, from 3:16PM ET on Sunday Dec 01, 2024 by Accesswire

ADMA Biologics, Inc. Is Being Investigated For Fraud And Impacted Investors Are Invited To Contact The Schall Law Firm, from 3:16PM ET on Sunday Dec 01, 2024 by Dow Jones

Nov 30, 2024

The Schall Law Firm Encourages Shareholders With Losses To Join An Inquiry Into ADMA Biologics Inc For Securities Law Violations, from 11:01AM ET on Saturday Nov 30, 2024 by Accesswire

The Schall Law Firm Encourages Shareholders With Losses To Join An Inquiry Into ADMA Biologics Inc For Securities Law Violations, from 11:01AM ET on Saturday Nov 30, 2024 by Dow Jones

Nov 29, 2024

ADMA Biologics, Inc. Is Being Investigated For Committing Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm, from 12:31PM ET on Friday Nov 29, 2024 by Accesswire

ADMA Biologics, Inc. Is Being Investigated For Committing Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm, from 12:30PM ET on Friday Nov 29, 2024 by Dow Jones

TG Therapeutics to Participate in the Evercore HealthCONx Conference, from 8:00AM ET on Friday Nov 29, 2024 by Dow Jones

Nov 27, 2024

The Schall Law Firm Invites Stockholder Contributions To An Inquiry Into ADMA Biologics Inc's Securities Law Violations, from 12:45PM ET on Wednesday Nov 27, 2024 by Accesswire